Literature DB >> 19540110

Purification and characterization of angiotensin I converting enzyme inhibitory peptides from the rotifer, Brachionus rotundiformis.

Jung Kwon Lee1, Suhee Hong, Joong-Kyun Jeon, Se-Kwon Kim, Hee-Guk Byun.   

Abstract

Angiotensin I converting enzyme (ACE) inhibitory peptide was isolated from the marine rotifer, Brachionus rotundiformis. ACE inhibitory peptides were separated from rotifer hydrolysate prepared by Alcalase, alpha-chymotrypsin, Neutrase, papain, and trypsin. The Alcalase hydrolysate had the highest ACE inhibitory activity compared to the other hydrolysates. The IC(50) value of Alcalase hydrolysate for ACE inhibitory activity was 0.63 mg/ml. We attempted to isolate ACE inhibitory peptides from Alcalase prepared rotifer hydrolysate using gel filtration on a Sephadex G-25 column and high performance liquid chromatography on an ODS column. The IC(50) value of purified ACE inhibitory peptide was 9.64 microM, and Lineweaver-Burk plots suggest that the peptide purified from rotifer protein acts as a competitive inhibitor against ACE. Amino acid sequence of the peptide was identified as Asp-Asp-Thr-Gly-His-Asp-Phe-Glu-Asp-Thr-Gly-Glu-Ala-Met, with a molecular weight 1538 Da. The results of this study suggest that peptides derived from rotifers may be beneficial as anti-hypertension compounds in functional foods resource.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540110     DOI: 10.1016/j.biortech.2009.05.057

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  9 in total

Review 1.  Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry.

Authors:  Isuru Wijesekara; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2010-03-31       Impact factor: 5.118

2.  Stability and cytotoxicity of angiotensin-I-converting enzyme inhibitory peptides derived from bovine casein.

Authors:  Wei Wu; Pan-pan Yu; Feng-yang Zhang; Hong-xia Che; Zhan-mei Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2014-02       Impact factor: 3.066

3.  ACE inhibitory activity of pangasius catfish (Pangasius sutchi) skin and bone gelatin hydrolysate.

Authors:  Fatemeh Mahmoodani; Masomeh Ghassem; Abdul Salam Babji; Salma Mohamad Yusop; Roya Khosrokhavar
Journal:  J Food Sci Technol       Date:  2012-05-18       Impact factor: 2.701

4.  Effect of phlorotannins isolated from Ecklonia cava on angiotensin I-converting enzyme (ACE) inhibitory activity.

Authors:  W A J P Wijesinghe; Seok-Chun Ko; You-Jin Jeon
Journal:  Nutr Res Pract       Date:  2011-04-23       Impact factor: 1.926

5.  Isolation, purification and molecular mechanism of a peanut protein-derived ACE-inhibitory peptide.

Authors:  Aimin Shi; Hongzhi Liu; Li Liu; Hui Hu; Qiang Wang; Benu Adhikari
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

6.  Vicilin-A major storage protein of mungbean exhibits antioxidative potential, antiproliferative effects and ACE inhibitory activity.

Authors:  Neha Gupta; Nidhi Srivastava; Sameer S Bhagyawant
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

7.  Protective Effects of Novel Antioxidant Peptide Purified from Alcalase Hydrolysate of Velvet Antler Against Oxidative Stress in Chang Liver Cells in Vitro and in a Zebrafish Model In Vivo.

Authors:  Yuling Ding; Seok-Chun Ko; Sang-Ho Moon; Seung-Hong Lee
Journal:  Int J Mol Sci       Date:  2019-10-19       Impact factor: 5.923

8.  Enzyme Hydrolysates from Stichopus horrens as a New Source for Angiotensin-Converting Enzyme Inhibitory Peptides.

Authors:  Bita Forghani; Afshin Ebrahimpour; Jamilah Bakar; Azizah Abdul Hamid; Zaiton Hassan; Nazamid Saari
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-15       Impact factor: 2.629

9.  Antihypertensive effect of an enzymatic hydrolysate from Styela clava flesh tissue in type 2 diabetic patients with hypertension.

Authors:  Seok-Chun Ko; Won-Kyo Jung; Seung-Hong Lee; Dae Ho Lee; You-Jin Jeon
Journal:  Nutr Res Pract       Date:  2017-09-15       Impact factor: 1.926

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.